| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | RCC1 | 4.65e-04 | 20 | 30 | 2 | PF00415 | |
| Domain | RCC1_3 | 5.14e-04 | 21 | 30 | 2 | PS50012 | |
| Domain | RCC1_1 | 5.14e-04 | 21 | 30 | 2 | PS00625 | |
| Domain | RCC1_2 | 5.14e-04 | 21 | 30 | 2 | PS00626 | |
| Domain | Reg_chr_condens | 5.65e-04 | 22 | 30 | 2 | IPR000408 | |
| Domain | - | 5.65e-04 | 22 | 30 | 2 | 2.130.10.30 | |
| Domain | RCC1/BLIP-II | 6.18e-04 | 23 | 30 | 2 | IPR009091 | |
| Domain | PDZ | 1.47e-03 | 141 | 30 | 3 | PF00595 | |
| Domain | PDZ | 1.69e-03 | 148 | 30 | 3 | SM00228 | |
| Domain | - | 1.76e-03 | 150 | 30 | 3 | 2.30.42.10 | |
| Domain | PDZ | 1.79e-03 | 151 | 30 | 3 | PS50106 | |
| Domain | PDZ | 1.83e-03 | 152 | 30 | 3 | IPR001478 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 3.55e-06 | 477 | 31 | 6 | 31300519 | |
| Pubmed | 4.61e-06 | 4 | 31 | 2 | 20068575 | ||
| Pubmed | 6.42e-06 | 529 | 31 | 6 | 14621295 | ||
| Pubmed | 7.68e-06 | 5 | 31 | 2 | 2296595 | ||
| Pubmed | Samp1 is a component of TAN lines and is required for nuclear movement. | 1.15e-05 | 6 | 31 | 2 | 22349700 | |
| Pubmed | 2.15e-05 | 8 | 31 | 2 | 27582690 | ||
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | 2.61e-05 | 1021 | 31 | 7 | 26760575 | |
| Pubmed | Nesprin 1α2 is essential for mouse postnatal viability and nuclear positioning in skeletal muscle. | 3.44e-05 | 10 | 31 | 2 | 28533284 | |
| Pubmed | OLIG2 is an in vivo bookmarking transcription factor in the developing neural tube in mouse. | 3.44e-05 | 10 | 31 | 2 | 36547371 | |
| Pubmed | 3.44e-05 | 10 | 31 | 2 | 29990475 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 3.78e-05 | 1082 | 31 | 7 | 38697112 | |
| Pubmed | 4.21e-05 | 11 | 31 | 2 | 23637331 | ||
| Pubmed | 4.21e-05 | 11 | 31 | 2 | 30982771 | ||
| Pubmed | 4.21e-05 | 11 | 31 | 2 | 28814342 | ||
| Pubmed | A role for sustained MAPK activity in the mouse ventral telencephalon. | 5.96e-05 | 13 | 31 | 2 | 33775695 | |
| Pubmed | 6.95e-05 | 14 | 31 | 2 | 22820053 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 7.39e-05 | 1203 | 31 | 7 | 29180619 | |
| Pubmed | 8.07e-05 | 259 | 31 | 4 | 31162944 | ||
| Pubmed | KLHL40 deficiency destabilizes thin filament proteins and promotes nemaline myopathy. | 9.16e-05 | 16 | 31 | 2 | 24960163 | |
| Pubmed | 9.16e-05 | 16 | 31 | 2 | 24948600 | ||
| Pubmed | A conserved molecular logic for neurogenesis to gliogenesis switch in the cerebral cortex. | 9.16e-05 | 16 | 31 | 2 | 38713624 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 9.72e-05 | 1257 | 31 | 7 | 36526897 | |
| Pubmed | 1.04e-04 | 17 | 31 | 2 | 26187199 | ||
| Pubmed | 1.17e-04 | 18 | 31 | 2 | 22021915 | ||
| Pubmed | 1.18e-04 | 1297 | 31 | 7 | 33545068 | ||
| Pubmed | 1.30e-04 | 19 | 31 | 2 | 32234482 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | 1.32e-04 | 1321 | 31 | 7 | 27173435 | |
| Pubmed | 1.49e-04 | 304 | 31 | 4 | 32235678 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.53e-04 | 582 | 31 | 5 | 20467437 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 1.54e-04 | 583 | 31 | 5 | 29844126 | |
| Pubmed | ERK signaling expands mammalian cortical radial glial cells and extends the neurogenic period. | 1.60e-04 | 21 | 31 | 2 | 38498715 | |
| Pubmed | The small GTPase Rac1 regulates auditory hair cell morphogenesis. | 1.92e-04 | 23 | 31 | 2 | 20016102 | |
| Pubmed | Risk of meningomyelocele mediated by the common 22q11.2 deletion. | 2.28e-04 | 25 | 31 | 2 | 38696583 | |
| Pubmed | Loss of Gsx1 and Gsx2 function rescues distinct phenotypes in Dlx1/2 mutants. | 2.28e-04 | 25 | 31 | 2 | 23042297 | |
| Pubmed | 2.29e-04 | 340 | 31 | 4 | 29478914 | ||
| Pubmed | Olig1 function is required to repress dlx1/2 and interneuron production in Mammalian brain. | 2.47e-04 | 26 | 31 | 2 | 24507192 | |
| Pubmed | Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells. | 2.48e-04 | 137 | 31 | 3 | 37039823 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 2.50e-04 | 647 | 31 | 5 | 26618866 | |
| Pubmed | Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. | 2.66e-04 | 27 | 31 | 2 | 23144326 | |
| Pubmed | 2.85e-04 | 360 | 31 | 4 | 33111431 | ||
| Pubmed | 2.86e-04 | 28 | 31 | 2 | 30796806 | ||
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 3.05e-04 | 147 | 31 | 3 | 28977470 | |
| Pubmed | Identification of Redox and Glucose-Dependent Txnip Protein Interactions. | 3.75e-04 | 32 | 31 | 2 | 27437069 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 3.78e-04 | 1105 | 31 | 6 | 35748872 | |
| Pubmed | 4.05e-04 | 162 | 31 | 3 | 25796446 | ||
| Pubmed | 4.20e-04 | 399 | 31 | 4 | 35987950 | ||
| Pubmed | Rewiring of RSK-PDZ Interactome by Linear Motif Phosphorylation. | 4.24e-04 | 34 | 31 | 2 | 30726710 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 4.65e-04 | 1149 | 31 | 6 | 35446349 | |
| Pubmed | Delayed maturation and migration of excitatory neurons in the juvenile mouse paralaminar amygdala. | 5.30e-04 | 38 | 31 | 2 | 38086370 | |
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 6.06e-04 | 186 | 31 | 3 | 33637726 | |
| Pubmed | 6.07e-04 | 786 | 31 | 5 | 29128334 | ||
| Pubmed | 6.17e-04 | 41 | 31 | 2 | 19805454 | ||
| Pubmed | 6.47e-04 | 42 | 31 | 2 | 26166575 | ||
| Pubmed | 6.54e-04 | 191 | 31 | 3 | 31177093 | ||
| Pubmed | Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome. | 6.79e-04 | 43 | 31 | 2 | 34672947 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 6.99e-04 | 457 | 31 | 4 | 32344865 | |
| Pubmed | Roquin promotes constitutive mRNA decay via a conserved class of stem-loop recognition motifs. | 7.43e-04 | 45 | 31 | 2 | 23663784 | |
| GeneFamily | PDZ domain containing | 9.12e-04 | 152 | 23 | 3 | 1220 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-06 | 140 | 31 | 4 | 115bd770a9d5e6f007a9aa0eadf5dba46d500107 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-06 | 140 | 31 | 4 | 22d126e80bf7d9c0ca6ec686b5cc66fa584a1ab6 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-06 | 140 | 31 | 4 | 62d1ef8cb78618ed89cac7ec89d7f54de06a90c7 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 1.04e-05 | 198 | 31 | 4 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | URO-Lymphocyte-T_NK-Treg|URO / Disease, Lineage and Cell Type | 1.65e-04 | 154 | 31 | 3 | 73fe0e26088a1b012902cc062ffbb3e4d2ff09f9 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.71e-04 | 156 | 31 | 3 | c380142e49b1e4ecacbf37587aafa57f8562b6ad | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Platelet|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.84e-04 | 160 | 31 | 3 | 768f3cefc3ad4cda229e598cce8bde574cf64bb2 | |
| ToppCell | CV-Healthy-3|CV / Virus stimulation, Condition and Cluster | 1.88e-04 | 161 | 31 | 3 | fd4a79385ea967b9900dc76a3add813b894a3a28 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 162 | 31 | 3 | dddf7a3901ae59e3494d8a6740db0fa15cc96d47 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 162 | 31 | 3 | 2a4e09545e9874519f0f56e81065104987d81cd6 | |
| ToppCell | 11.5-Airway-RBC-RBC|Airway / Age, Tissue, Lineage and Cell class | 2.02e-04 | 165 | 31 | 3 | 8618b2c5659aa70c7c9d6e51a227ac612b4ad17b | |
| ToppCell | 11.5-Airway-RBC|Airway / Age, Tissue, Lineage and Cell class | 2.02e-04 | 165 | 31 | 3 | 46042340a373adaf1c439b2301e02fbae3e31a4f | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-04 | 167 | 31 | 3 | a66552667aa6e8992c159df27a57c2e8ae14a9ce | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-04 | 167 | 31 | 3 | 1248f809afbcccb42ce9e29cfe6fa1f6f6b65005 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-04 | 170 | 31 | 3 | 8465c3069bbc08705d070927e712b6bc85ac7c5b | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.28e-04 | 172 | 31 | 3 | 490745024730df6357f6c2b81d7a64e21557c0d5 | |
| ToppCell | droplet-Spleen-nan-21m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 172 | 31 | 3 | 3dc02709c2a6be2155576e5c34e1b0b3ae19b061 | |
| ToppCell | COVID-19-lung-RBC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.40e-04 | 175 | 31 | 3 | 4c35292ad2ac712ba7516f27dd6eac6ba8fdd163 | |
| ToppCell | 18-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class | 2.40e-04 | 175 | 31 | 3 | cc476b4244442418b8f21721a82a36209b556b36 | |
| ToppCell | 18-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class | 2.40e-04 | 175 | 31 | 3 | 7130b816e0c02309c161d8e9ad7cb4bc2469e251 | |
| ToppCell | droplet-Spleen-nan-21m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 176 | 31 | 3 | 11067b649fe21ac2bb328829ecadc2f64c2c10aa | |
| ToppCell | droplet-Spleen-nan-21m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-04 | 176 | 31 | 3 | 130238f0707541c511f479619c4f7a3593ef0ebf | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.44e-04 | 176 | 31 | 3 | 238244294d08975df6bfa26b2b437db3654408ae | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-04 | 177 | 31 | 3 | 84591e28482ab62a5ef41e61043eb64912766356 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-04 | 177 | 31 | 3 | 4bc100062891d07cacd10ffba38966cc6302c92f | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-04 | 177 | 31 | 3 | 9f3a2adb9cd4f0a059afc87b6e377a9702154bb1 | |
| ToppCell | Endothelial-A-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 2.52e-04 | 178 | 31 | 3 | 2f2602b9305d55f25afa9861dd6c6347ae179337 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Primitive_erythrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.56e-04 | 179 | 31 | 3 | 3c8046f43da5a02fa4278a7175b9cd8cf95b8e27 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic-platelet|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.61e-04 | 180 | 31 | 3 | beb4d777e0c5fa0a59672dbc3dbb7732498605ff | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-hematologic-thrombocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.61e-04 | 180 | 31 | 3 | fb3d549c2a69b2157a486786ddd775ca16699ed0 | |
| ToppCell | droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 182 | 31 | 3 | b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01 | |
| ToppCell | PCW_07-8.5-Hematologic_ErythroMegGranulo-Hem_ErythroMeg|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.87e-04 | 186 | 31 | 3 | 3b60a153e6cfc1b977a1f8b8f3bcaf75d1f4ff5b | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 192 | 31 | 3 | d525f7f088a53110912600a7c9f6d33b9270d534 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-04 | 192 | 31 | 3 | 2bfac6b3956265205ca47d06888851ed68b65999 | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.20e-04 | 193 | 31 | 3 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | 10x5'-blood|World / Manually curated celltypes from each tissue | 3.20e-04 | 193 | 31 | 3 | 359d4242a7e5e51a3eaf6fe51bc1c653a402b054 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.25e-04 | 194 | 31 | 3 | ecdfc27d06e363fb23f0309f26ef6404a89f14ec | |
| ToppCell | Mild-CD8+_T|World / Disease group and Cell class | 3.25e-04 | 194 | 31 | 3 | d64c2efb482bcdef9240977eae1023c4191286e7 | |
| ToppCell | (1)_T_CD8_CTL|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.30e-04 | 195 | 31 | 3 | f582b854e5a4c52764aad5abe4e28ea77a7445f7 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.30e-04 | 195 | 31 | 3 | 027075e9c62b5754a014a9d1393e1b0f5ae42e41 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 3.30e-04 | 195 | 31 | 3 | bff726515ea9ce82c223e6c805000afe2e9b7206 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Myeloid-Megakaryocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.30e-04 | 195 | 31 | 3 | 1bcc0c8b1281396b1433ce5a2ec8681de47ce9ad | |
| ToppCell | (1)_T_cells-(1)_T_CD8_CTL|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.34e-04 | 196 | 31 | 3 | ad9b0651cb2a15b750e453b2dcf782bca08b4fe7 | |
| ToppCell | critical-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.34e-04 | 196 | 31 | 3 | c861f017aa9050282aa81c5a445bae399df00e4f | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.34e-04 | 196 | 31 | 3 | af00c31612e4fe068e5fccae05368edba46bbd20 | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-Treg|URO / Disease, condition lineage and cell class | 3.34e-04 | 196 | 31 | 3 | 8812d7365fb2b33feff93782d60776e932499a43 | |
| ToppCell | severe-Lymphocytic-CD8_T_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.34e-04 | 196 | 31 | 3 | d83acd9abd7b296989b8ae09da63799e6877a149 | |
| ToppCell | mild-Lymphocytic-CD8_T_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.40e-04 | 197 | 31 | 3 | 8b0e4012e25641c3bcd3e9911031e43d9dbbff21 | |
| ToppCell | T_cells-CTLs|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.40e-04 | 197 | 31 | 3 | 28117cf300e169182571fbad0de1681a484a435a | |
| ToppCell | T_cells-CTLs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.40e-04 | 197 | 31 | 3 | 2de34e20915a247bee75aa40495e23c20bb23e18 | |
| ToppCell | CD8+_Memory_T_cell-CV|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.45e-04 | 198 | 31 | 3 | 3d1749f5106f0912f4a74615863853949f52c73d | |
| ToppCell | (0)_NK_cells-(0)_NK_FCGR3Apos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.45e-04 | 198 | 31 | 3 | eba39656c6f699ab297b652ded8cb9727b49593c | |
| ToppCell | mild-Lymphocytic-CD8_T_cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.45e-04 | 198 | 31 | 3 | 629a1229759f3088cafb36f27a3d19d7249aab3a | |
| ToppCell | control-Lymphocytic-NK_cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.45e-04 | 198 | 31 | 3 | 1c779101d0c5f29de5cc7170d784931d6e34bdcd | |
| ToppCell | severe-Lymphocytic-CD8_T_cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.45e-04 | 198 | 31 | 3 | 2cd13418396ab2c53b1be96e7795841c2482bfca | |
| ToppCell | moderate-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.45e-04 | 198 | 31 | 3 | 0a868098b1ee4b28b2149ed766acb09e9c0ce14c | |
| ToppCell | ASK440|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.45e-04 | 198 | 31 | 3 | f3ed6efd521c691debae32a803972bed5d069332 | |
| ToppCell | B_cells-Activate_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 3.45e-04 | 198 | 31 | 3 | a663082d7fbd6db11d3d3024bbb8ba00183e19f8 | |
| ToppCell | CV|World / Virus stimulation, Condition and Cluster | 3.45e-04 | 198 | 31 | 3 | 6a28193af35abec5c029129930c2ca6febaafde2 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.50e-04 | 199 | 31 | 3 | 00ef3cc5c02639bfb839075ecf5f20026ff81f84 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.55e-04 | 200 | 31 | 3 | af43f6d0e03b77f5eca1762e7b2be1d244d47664 | |
| ToppCell | healthy_donor|World / Disease condition, Lineage, Cell class and subclass | 3.55e-04 | 200 | 31 | 3 | afd4d5609adaa470e3d880f8be4a4d55e162b3d6 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.55e-04 | 200 | 31 | 3 | 64c2399c78e4ce0f05893d856bf90b1d3f5dba03 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.55e-04 | 200 | 31 | 3 | 94d4f690bf5b87866c0840715396d360b1737d11 | |
| ToppCell | remission-CD8+_Tem|World / disease stage, cell group and cell class | 3.55e-04 | 200 | 31 | 3 | 0ebf0dda91fc7adb9ea69734ad9dcc65d0082c6d | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-CD8+_Tem|COVID-19_Convalescent / Disease group, lineage and cell class | 3.55e-04 | 200 | 31 | 3 | 3f00839697183a1066548930b9ec3664b3568afc | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-CD8+_Tem|COVID-19_Convalescent / Disease, condition lineage and cell class | 3.55e-04 | 200 | 31 | 3 | 7c8a5465b478f430495942151c36020023d9bac9 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.55e-04 | 200 | 31 | 3 | f692b602bc989d35c9162e73dda813dbef8d5267 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.55e-04 | 200 | 31 | 3 | 63077e1f801f1c08bd339f5517f5781da240c04f | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.55e-04 | 200 | 31 | 3 | f0452dc1056b5ea492e61b20bb52815a5d2f705e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.55e-04 | 200 | 31 | 3 | 2bd8c35484fe6b0bc0f9314216786baaa97d1e95 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.55e-04 | 200 | 31 | 3 | 024eafabb576bfb835452def941237a35eebb912 | |
| ToppCell | remission-CD8+_Tem|remission / disease stage, cell group and cell class | 3.55e-04 | 200 | 31 | 3 | f1e4b8fcb422727f665f22b48f34bee23f0fad52 | |
| Drug | Alprenolol hydrochloride [13707-88-5]; Up 200; 14uM; MCF7; HT_HG-U133A | 5.90e-06 | 193 | 31 | 5 | 6789_UP | |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Up 200; 3uM; MCF7; HT_HG-U133A | 6.52e-06 | 197 | 31 | 5 | 6840_UP | |
| Drug | Cefotiam hydrochloride; Up 200; 7.2uM; MCF7; HT_HG-U133A | 6.52e-06 | 197 | 31 | 5 | 3319_UP | |
| Disease | chronic obstructive pulmonary disease, CC16 measurement | 1.60e-05 | 6 | 31 | 2 | EFO_0000341, EFO_0005080 | |
| Disease | N-acetyl-2-aminooctanoate measurement | 7.00e-05 | 12 | 31 | 2 | EFO_0800567 | |
| Disease | Nonorganic psychosis | 2.40e-03 | 69 | 31 | 2 | C0349204 | |
| Disease | mean platelet volume | 3.93e-03 | 1020 | 31 | 5 | EFO_0004584 | |
| Disease | Psychotic Disorders | 5.06e-03 | 101 | 31 | 2 | C0033975 | |
| Disease | immature platelet count | 5.55e-03 | 106 | 31 | 2 | EFO_0803544 | |
| Disease | immature platelet fraction | 6.39e-03 | 114 | 31 | 2 | EFO_0009187 | |
| Disease | immature platelet measurement | 6.95e-03 | 119 | 31 | 2 | EFO_0803541 | |
| Disease | nasopharyngeal neoplasm | 1.10e-02 | 151 | 31 | 2 | EFO_0004252 | |
| Disease | Paroxysmal atrial fibrillation | 1.17e-02 | 156 | 31 | 2 | C0235480 | |
| Disease | Persistent atrial fibrillation | 1.17e-02 | 156 | 31 | 2 | C2585653 | |
| Disease | familial atrial fibrillation | 1.17e-02 | 156 | 31 | 2 | C3468561 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RHGGKKDGSGGASGT | 6 | Q9NYV4 | |
| EIGGAFGGEKHTGGG | 491 | P49419 | |
| FGGEKHTGGGRESGS | 496 | P49419 | |
| GGLGSKSKGHYEVTG | 5826 | Q09666 | |
| HEGLGISITGGKEHG | 296 | Q9HD26 | |
| ISGMAGGRGSGGHAL | 391 | Q8WXD9 | |
| SGFGQHGSGTGKSSG | 1126 | Q5D862 | |
| HKRHSVVAGGGGGEG | 1036 | Q6PKG0 | |
| TVTVGGSGGDKGSGF | 316 | P16150 | |
| VLGTGTGGSGGFHLA | 451 | Q03252 | |
| FGLGTVGHTGGKGES | 1686 | Q15751 | |
| LTHGSGGKGYGLAST | 2051 | Q15751 | |
| GGKGYGLASTGVTSG | 2056 | Q15751 | |
| TGSGKTYTIGGGHIA | 86 | Q86VH2 | |
| GGGGGFVVSIHSGLA | 126 | P09131 | |
| GGIFDKAVSTGGGGH | 411 | P18054 | |
| GGHAGTTYIFGKGGA | 86 | P58401 | |
| GKYGKTGSAGARGHT | 111 | Q9BXJ1 | |
| KNSGSGGGLSGMGHT | 206 | O15063 | |
| ASGLTGSIVGHVGDG | 411 | Q86WU2 | |
| EGEGGTHSHGVKTGQ | 146 | O15547 | |
| VTGTGGGISLKHGDE | 41 | Q96GX9 | |
| GGGGHSAVVTDGGDL | 56 | Q9UGK8 | |
| VHSLGGGTGSGMGTL | 136 | Q9H4B7 | |
| SAGAHPGDKLGGSGF | 61 | Q13516 | |
| GLGFSIRGGSEHGVG | 151 | Q9P202 | |
| LSKHVKTHSGGGGGG | 431 | Q8IXZ3 | |
| GSAGSGSGGKKGSDT | 446 | Q8IXZ3 | |
| GSSGHELSALGGEGG | 141 | Q16186 | |
| NGSGHIGSSVGGAKF | 791 | P61129 | |
| GQGGGGGLSHEDTLA | 316 | Q9UH99 | |
| THFQGDKESGGTGEG | 746 | O15015 | |
| KKHKHRSGGSGGSGG | 36 | O43290 | |
| DGAGKTPTLGGGFHV | 61 | Q92994 | |
| VISSDGHNGLGKGFG | 21 | O95881 |